Interviews
Business Mag
– September 2017
“Axonova capitalise sur la biodiversité régionale”
Read the interview of Dr Fabien Boullé describing the importance of the regional biodiversity and how Axonova is exploring our natural resources to identify novel bioactive ingredients for use as therapeutics.
DefiMedia.info
– August 2018
“Je veux contribuer significativement à l’essor des biotechnologies’’
In this extract, Dr Fabien Boullé explains why Mauritius is the chosen destination for his vision and how Axonova is contributing to the establishment of the Biotech ecosystem of the country.
EDB newsletter
– September 2020
‘’Highlight of the Month, Interview of Dr Fabien Boullé’’
Axonova was featured in the EDB Newsletter as a key player in the establishment of a Nutraceutical framework in Mauritius. In this issue, Dr Fabien Boullé elaborates on Axonova’s role in the development of the sector.
Business Mag- Votre Santé +
– December 2021
‘’Un des pionniers de la recherche en nutraceutique à Maurice’’
Axonova is presented as one of the pioneers in the nutraceutical sector in Mauritius. In this write-up Dr Boullé emphasises on how Axonova’s bioactive screening strategies in collaboration with international partners have helped identify promising candidates for health applications.
Scientific Communication
Coming soon
In the News
Axonova was awarded the MRIC Special Call Grant ‘’Building Blue Resilience through Innovation’’ for the project entitled ‘’Plant-assisted bacterial bioremediation as an innovative approach for targeting crude oil degradation’’.
See extract from the Mauritius Broadcasting Corporation News coverage for details of the project, led by our Research Scientist, Piteesha Ramlagan.
Interviews
Business Mag
– September 2017
‘Axonova capitalise sur la biodiversité régionale’
Read the interview of Dr Fabien Boullé describing the importance of the regional biodiversity and how Axonova is exploring our natural resources to identify novel bioactive ingredients for use as therapeutics.
DefiMedia.info
– August 2018
‘Je veux contribuer significativement à l’essor des biotechnologies’’
In this extract, Dr Fabien Boullé explains why Mauritius is the chosen destination for his vision and how Axonova is contributing to the establishment of the Biotech ecosystem of the country.
EDB newsletter
– September 2020
‘’Highlight of the Month, Interview of Dr Fabien Boullé’’
Axonova was featured in the EDB Newsletter as a key player in the establishment of a Nutraceutical framework in Mauritius. In this issue, Dr Fabien Boullé elaborates on Axonova’s role in the development of the sector.
Business Mag- Votre Santé +
– December 2021
‘’Un des pionniers de la recherche en nutraceutique à Maurice’’
Axonova is presented as one of the pioneers in the nutraceutical sector in Mauritius. In this write-up Dr Boullé emphasises on how Axonova’s bioactive screening strategies in collaboration with international partners have helped identify promising candidates for health applications.
Scientific Communication
No information available
In the News
Axonova was awarded the MRIC Special Call Grant ‘’Building Blue Resilience through Innovation’’ for the project entitled ‘’Plant-assisted bacterial bioremediation as an innovative approach for targeting crude oil degradation’’.
See extract from the Mauritius Broadcasting Corporation News coverage for details of the project, led by our Research Scientist, Piteesha Ramlagan.
contact@axonova-pharma.com
+230 634 0130
